Dr. Mark Rampy is an accomplished life sciences executive, entrepreneur and investor with more than 25 years of experience spanning early-stage ventures to publicly traded pharmaceutical and biotechnology companies. He has held senior leadership roles at organizations including Human Genome Sciences, Inc., CoGenesys Inc., Teva Pharmaceuticals, and multiple start-up companies. Mark has a proven track record of building and growing innovative companies and brings deep expertise in business and corporate strategy, business development, licensing and strategic alliances, technology and product development. He holds a B.A. in Chemistry and Economics from Kalamazoo College, a Ph.D. in Pharmacology from the University of Michigan, and an M.B.A. from Georgetown University.